IDEXX Laboratories, Inc. - Common Stock (IDXX)
$458.97
0.89 (0.19%)
IDXX Stock Quote Delayed 30 Minutes
These 7 Pet Care Stocks Will Reduce the Cost of Pet Ownership
Global pet care sales could hit $203 billion by 2025. Here are seven pet care stocks to buy from the only pet care ETF in the U.S.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
39.05B
PE Ratio
43.01
EPS
10.67
Volume (Avg. Vol.)
265,037
Day's Range
$455.69 - $465.04
52-Week Range
$398.50 - $583.39
Dividend & Yield
N/A (N/A)
IDXX Stock Predictions, Articles, and IDEXX Laboratories, Inc. - Common Stock News
Quant Score Make IDEXX Laboratories (IDXX) a Buy
The current recommendation of Buy for IDEXX Laboratories Inc (NASDAQ:IDXX) has been derived by using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking IDXX has had from Portfolio Grader for 3 months.
Idexx Laboratories, Inc. (IDXX) Stock Is for the Birds … And Dogs and Cats
With U.S. spending on our furry friends continuing to climb, Idexx Laboratories is well positioned for long-term growth and IDXX stock is worth a look.
